ASPL Home

The American Society for Pharmacy Law (ASPL) is the organization of attorneys, pharmacists, pharmacist-attorneys and students of pharmacy or law who are interested in the law as it applies to pharmacy, pharmacists, wholesalers, manufacturers, state and federal government and other interested parties.

ASPL is a nonprofit organization with the purposes of

Furthering knowledge in the law related to pharmacists, pharmacies, the provision of pharmaceutical care, the manufacturing and distribution of drugs, and other food, drug, and medical device policy issues;
Communicating accurate legal educational information; and
Providing educational opportunities for pharmacists, attorneys, and others who are interested in pharmacy law

ASPL Programs & Services

Annual Educational Programs

Educational sessions at the Annual Developments in Pharmacy Law Seminar (CLE and Pharmacy CE)
Pharmacy Law track at the annual APhA Annual Meeting and Exposition

Legal Services

Looking for someone with expertise in both pharmacy and law? Check ASPL’s Attorney Referral or Expert Witness Services to find someone in your state. If you are an ASPL member and have not signed up for these two services and wish to be listed, contact us.

Breaking Legal News and Regular Legal Updates (Must be an ASPL member to access.) JOIN NOW

Rx Ipsa Loquitur - bimonthly newsletter focusing on trends in Pharmacy Law
PHARMA-LAW E-News - monthly e-newsletter reviewing cases, legislation and regulations

The Benefits of Membership

Exclusive monthly reviews of major jurisprudence, legislation, and regulation regarding pharmacy law
Preferred registration rates and priorities for annual events
Access to an on-line Membership Directory.

Aaron Moore, ASPL board member, appeared on The Pharmacy Podcast in September, 2016. The Pharmacy Podcast has nearly 60,000 subscribers around the world and focuses on the business of pharmacy.

Learn more about the benefits of ASPL membership! Listen to this ASPL podcast

Quick Links

Latest News

April 8, 2019

LANHAM ACT
Are retailers potentially liable under the Lanham Act for displaying and selling products whose labeling contains false claims?
In an ongoing battle between manufacturers of “male dietary products,” Outlaw Laboratory, LP, which makes the “Tristeel” product line, filed suit in Texas federal court against the manufacturer and 14 convenience stores/gas stations that sold “Rhino” products made by Shenoor Enterprise, Inc. The case was grounded in the Lanham Act and alleges that the label statements on the Rhino product line claimed that the products are “all natural” and contain “no harmful synthetic chemicals.” These statements are allegedly false because Rhino products have been shown to contain “dangerous undisclosed ingredients” typically found only in prescription drugs, not OTC products. The claim is based on FDA announcements that Rhino products were tested and found to contain sildenafil and other chemicals.

The Court dismissed the suit on motions by some of the retailer defendants for failure to state a claim. In reaching this conclusion, the Court found that the defendant retailers had not on their own made a false statement in the context of commercial advertising or promotion – they merely displayed and sold the products as labeled by Shenoor. However, the Court held open the possibility that under a different set of facts, the retailers could be found liable for violations of the Lanham Act, provided that the retailers could be shown to have taken an active role in creation and/or dissemination of the false claims. [Outlaw Laboratory, LP v. Shenoor Enterprise, Inc., et al., No. 3-18-CV-2299-B, N.D. Tex., March 4, 2019]

Announcements

SAVE THE DATE!
DPL XXX Seminar
November 7-10, 2019
Westin San Diego Gaslamp Quarter